Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of the combined company. Kenvue shareholders will own about 46%. The combined company will have a large stable of household brands under one roof, putting … Read more